X0306 4 2020-02-25 false 0001410098 CorMedix Inc. CRMD 0001735256 Masson Elizabeth C/O CORMEDIX INC. 400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS NJ 07922 false true false false EVP, Head of Clinical Ops. Common Stock 8000.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2020-02-25 4 A false 24764.0000 5.6300 A 2030-02-25 Common Stock 24764.0000 24764.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 20880.0000 20880.0000 D Stock Option (Right to Buy Common Stock) 1.4500 2028-03-19 Common Stock 54000.0000 54000.0000 D These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase 2,100 shares that are subject to vesting each on January 10, 2021 and January 10, 2022. The options vest as follows: 186,000 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vest on the achievement of certain milestones, subject to continued employment. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Elizabeth Masson 2020-02-27